The drug prices review board was once a solution. It’s now a problem.

Financial Post

1 March 2023 - Anti-drug company activists are repeating ill-informed myths about controlling drug prices in Canada.

Journalist Kelly Crowe and others repeat the falsehood that Canada has some of the highest drug list prices in the world, ignoring the billions of dollars in discounts various Canadian purchasers receive. Ms. Crowe suggests withdrawal of proposed new regulations for the Patented Medicine Prices Review Board was due to federal Minister of Health Jean-Yves Duclos capitulating to the biopharmaceutical industry.

Read Financial Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Canada